Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On Active Substances (medicines) Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Combination Umeclidinium Bromide | Vilanterol Trifenatate - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Combination Fluticason Furoate | Vilanterol Trifenatate - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement According To Section 130a Paragraph 8 Sgb V For The Active Ingredient Combination Indacaterol Maleate | Glycopyrronium Bromide - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Abatacept - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Agalsidase Beta - Vv 80 2026-08-10
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb) V For The Active Ingredient Tobramycin (hpi) - Vv 80 2026-08-10
Finland Digital Doctor Service (dps) 2026-08-24
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Drospirenone And Ethinylestradiol (atc Code 2026-08-27
United States Open Enrollment - Clinical Examiners 2026-08-31
Whats app